Gland Pharma gets USFDA EIR for Pashamylaram Facility Ruchika Sharma26 Sep 2023 10:00 AM GMTHyderabad: Gland Pharma has announced that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration...
Gland Pharma names Ankit Gupta as Vice-President (Strategy and Investments) Ruchika Sharma5 Sep 2023 11:03 AM GMTTelangana: Gland Pharma has announced that Ankit Gupta has been appointed as Vice-President (Strategy & Investments), a Senior Management...
Gland Pharma gets 2 USFDA observations for Pashamylaram Facility Ruchika Sharma28 Aug 2023 9:00 AM GMTTelangana: Gland Pharma has announced that the Office of Medical Device and Radiological Health Operations (OMDRHO), United States Food and...
Gland Pharma receives USFDA EIR for Dundigal Facility Ruchika Sharma24 Aug 2023 11:00 AM GMTHyderabad: Through a recent BSE filing, Gland Pharma has informed that the Company has received an Establishment Inspection Report (EIR) from the US...
Gland Pharma reports 41 percent jump in Q1 revenue Ruchika Sharma8 Aug 2023 9:00 AM GMTGland Pharma, majority owned by China's Shanghai Fosun Pharmaceutical Group Co, however, reported a 15.3% fall in profit to 1.94 billion rupees for...
USFDA concludes inspection at Gland Pharma Visakhapatnam facility with zero 483 observations Ruchika Sharma31 July 2023 5:57 AM GMTTelangana: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice...
Gland Pharma gets one 483 Observation from USFDA for Dundigal facility Ruchika Sharma14 July 2023 7:59 AM GMTHyderabad: Gland Pharma today announced that the United States Food and Drug Administration (USFDA) has issued one 483 Observation...
Gland Pharma reports 56 percent decline in Q4 profit on soft demand Ruchika Sharma19 May 2023 8:00 AM GMTThe company operated in a "challenging business environment (in the year ended March)," Gland Pharma CEO Srinivas Sadu said in a statement.
Fosun Pharma withdraws plans to sell stake in Gland Pharma Ruchika Sharma26 April 2023 6:07 AM GMTBengaluru: China's Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in Indian drugmaker Gland Pharma Ltd, ET Now...
Hetero, Sun Pharma recall products in US over manufacturing issues Ruchika Sharma24 April 2023 6:45 AM GMTHetero USA Inc is recalling 2,352 bottles of Pantoprazole Sodium delayed release tablets for "CGMP Deviations: Discoloration", the USFDA stated.
Gland Pharma to infuse Rs 400 crore to expand Genome Valley facility Ruchika Sharma21 Feb 2023 6:05 AM GMTRama Rao said,"I am delighted that Gland Pharma will be investing Rs 400 crores in expanding their footprint in Hyderabad and will create 500 more...
USFDA issues zero observations for Gland Pharma Visakhapatnam API facility Ruchika Sharma28 Jan 2023 7:30 AM GMTVisakhapatnam: Gland Pharma has recently announced that the company has received zero observations from the US Food and Drug Administration (USFDA)...
